-
Goodbye BMI? Why Body Composition Is Gaining Ground in Clinics
The rise of incretin-based therapies for obesity care, like Wegovy (semaglutide) and Zepbound (tirzepatide), has brought renewed attention to the risk of muscle atrophy that can accompany rapid weight loss. To better assess…
-
What Is Type 5 Diabetes? Exploring the Newest Diagnostic Category
If you’ve seen a new diabetes diagnosis category circulating in medical circles and found yourself confused, thinking, “I don’t remember learning about that type in medical, nursing, or dietetics school,” don’t worry. It’s…
-
DCES Leadership in the Future of Wearable Health Technology
In a recent issue of Healthcare150, a newsletter spotlighting key healthcare trends, I was struck by the projected growth of wearable devices—from $14.5 billion in 2020 to $76.1 billion by 2029. In my…
-
GLP-1 Therapy Part 4: Navigating the Decision to Discontinue
I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment. This premier event,…
-
GLP-1 Therapy Part 3: Strategies for Successful Weight Loss
I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment. This premier event,…
Diabetes Care and Education
